A Phase I Trial of High-Dose Ascorbate in Glioblastoma Multiforme

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01752491
Recruitment Status : Active, not recruiting
First Posted : December 19, 2012
Last Update Posted : July 19, 2018
National Institutes of Health (NIH)
National Cancer Institute (NCI)
Information provided by (Responsible Party):
John M. Buatti, University of Iowa